FNYS
IMMU

First New York Securities’s Immunomedics Inc IMMU Stock Holding History

First New York Securities’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,990
Closed -$27K – 500
2013
Q2 		$27K Buy
+4,990
New +$16.4K 0.01% 329

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
SCM
Sigma Capital Management Stamford, Connecticut $1.95B AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

First New York Securities's IMMU Position: Q3 2013 in Review

First New York Securities sold out of Immunomedics Inc (IMMU) in Q3 2013, closing a stake of 4,990 shares — an estimated $27K sold.

First New York Securities first reported a position in IMMU in Q2 2013 and held it in 1 quarter. The position peaked at $27K in Q2 2013. 83 funds tracked by Wall St. Rank hold IMMU as of Q3 2013.

  • First New York Securities reported no remaining Immunomedics Inc position as of Q3 2013 after selling out during the quarter.
  • First New York Securities sold 4,990 Immunomedics Inc shares in Q3 2013, an estimated $27K.
  • First New York Securities first reported a position in Immunomedics Inc in Q2 2013 and held it in 1 quarter.
  • First New York Securities's Immunomedics Inc position peaked at $27K in Q2 2013.
  • 83 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2013.

Based on First New York Securities's 13F filing for Q3 2013, filed 6 Nov 2013.